Shanthi Rexaline

Shanthi is a contributor to InvestorPlace.com and works as a Staff Writer with Benzinga. Equipped with a Bachelor’s degree in Agriculture and an MBA with specialization in finance and marketing, she has about two decades of experience in financial reporting and analysis, and specializes in the biopharma and EV sectors.

Recent Articles

7 Electric Vehicle Stocks to Buy on the Dip

By Shanthi Rexaline

These commercial-stage electric vehicle stocks to buy have a history of strong execution and solid balance sheets.

3 Oversold Dividend Stocks to Buy Now

By Shanthi Rexaline

The stock market is presently in shambles and a resolution isn’t close at sight. What better way to insulate yourselves against the volatility than to invest in oversold dividend-paying stocks.

7 Biotech Stocks With Key Catalysts for May

By Shanthi Rexaline

The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.

3 Semiconductor Stocks to Buy for May 2022

By Shanthi Rexaline

Despite fears of a semiconductor cycle correction, the industry is poised to growth strongly, thanks to solid uptake of memory chips and 5G migration.

7 EV Stocks to Buy Following Toyota’s EV SUV Launch

By Shanthi Rexaline

Beaten-down EV stocks can draw inspiration from new product launches scheduled for the year. This will serve to accelerate EV adoption.

Load More